Navigation Links
Nektar to Announce Financial Results for the Third Quarter of 2008 on Thursday, November 6, 2008 After Close of U.S.-Based Financial Markets
Date:10/23/2008

SAN CARLOS, Calif., Oct 23 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter ended September 30, 2008 on Thursday, November 6, 2008, after the close of U.S.-based financial markets. Howard Robin, president and chief executive officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT).

The press release and a live audio-only Webcast of the conference call can be accessed through a link that is posted on the home page and Investor Relations section of the Nektar website: http://www.nektar.com.

To access the conference call, follow these instructions:

Dial: 866.362.4666 (U.S.); 617.597.5313 (international)

Participant Passcode: 63756947 (Howard Robin is the host)

An audio replay will also be available shortly after the call and will remain so through November 20, 2008.

To access the replay, follow these instructions:

Dial: 888-286-8010 (U.S.); 617-801-6888 (international)

Participant Passcode: 41304675

In the event that any non-GAAP financial measure is discussed on the conference call that is not described in the press release, related information will be made available on the Investor Relations page at the Nektar website as soon as practical after the conclusion of the conference call.

About Nektar

Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and conjugate chemistry technology platforms. Nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biop
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Nektar Therapeutics Announces Second Quarter 2008 Results
2. Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer
3. Nektar Therapeutics Announces First Quarter 2008 Results
4. FDA Approval of Cimzia(R) for Crohns Disease Represents Latest Milestone for Nektars PEGylation Technology Platform
5. Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results
6. Nektar to Announce 2007 Year-End Financial Results on Wednesday, February 27, 2008, After Close of U.S.-Based Financial Markets
7. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
8. Nektar Announces Agreement With Baxter to Develop New PEGylated Therapeutics for Hemophilia
9. Nektars Leading PEGylation and Pulmonary Technology Platforms Featured at R&D Day in New York
10. Nektar Therapeutics Announces Third Quarter 2007 Financial Results
11. Nektar to Announce Third Quarter 2007 Financial Results on Wednesday, November 7, 2007, After the Close of U.S. Financial Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Claflin Medical Equipment, headquartered in ... has signed a new, five year contract for medical ... Under the contract, the company will provide VA Hospitals ... Indian Health Services, National Institute of Health, and other ... pricing for hospital equipment and related services. Claflin looks ...
(Date:3/3/2015)... Pass, OR (PRWEB) March 03, 2015 ... stroke severity* confirms what water advocate and radio host ... that dehydration – lack of sufficient water in the ... as much as 90 percent of the US population. ... dehydration is a factor in nearly all disease, including ...
(Date:3/3/2015)... 2015 The physicians at Diet Doc ... loss product that is being recommended by fast weight ... contains ingredients that help people lose weight while improving ... diet product thought to possess innovative solutions to the ... ingredients, all directed at targeting specific strategic points for ...
(Date:3/3/2015)... St.Louis, MO (PRWEB) March 03, 2015 Extend ... shown to reduce the amount of calories consumed at the ... “Snack-2-Health Kit.” There are no lifestyle changes needed ... eat 2 snacks per day. , The starter kit contains ... contains a patented blend of protein, fiber, healthy fat and ...
(Date:3/3/2015)... The Data 360 Conference on “Healthcare’s Big ... Dearborn, MI, on March 5, 2015. Norman T. Kutemperor, ... He is known internationally as “The Father of NoSQL” and ... earned due to years of R&D on NoSQL DBs, culminating ... 10 years ago. Subsequent developments in Big Data-related technologies (such ...
Breaking Medicine News(10 mins):Health News:Claflin Medical Equipment (CME) Announces New 5 Year Contract with the Department of Veterans Affairs (VA) 2Health News:Study linking dehydration and stroke severity supports fresh water advocate’s warnings 2Health News:Study linking dehydration and stroke severity supports fresh water advocate’s warnings 3Health News:Diet Doc Discloses the Ingredients in their Powerful New Metabolism Boost for Controlled Appetite, Fast Weight Loss and Improved Mood 2Health News:Diet Doc Discloses the Ingredients in their Powerful New Metabolism Boost for Controlled Appetite, Fast Weight Loss and Improved Mood 3Health News:Diet Doc Discloses the Ingredients in their Powerful New Metabolism Boost for Controlled Appetite, Fast Weight Loss and Improved Mood 4Health News:Snack Your Way to a Smaller Waistline with Extend Nutrition’s New “Snack-2-Health Kit” 2Health News:Snack Your Way to a Smaller Waistline with Extend Nutrition’s New “Snack-2-Health Kit” 3Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 2Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 3Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 4
... ... still churning, innovations in technology will have a bottom-line impact on people’s ... health records, there is a new breed of technology aimed at preventative, ... online integrated health tracking tools, providing members ways to track, understand, and ...
... , Jan. 19 The National Theatre for Children ... with the only global entertainment brand dedicated to kids health, ... healthy exercise to the kids and families who need it most. ... will tour a curriculum-based and interactive live show – performed by ...
... , New Birth Defect Research Reveals ... Disorders , CELEBRATION, Fla. , Jan. 19 ... recorded in the National Birth Defect Registry (NBDR) also ... Defect Research for Children (BDRC) . The group reported that most ...
... researchers note , TUESDAY, Jan. 19 (HealthDay News) -- ... intensive care patients with the potentially lethal blood infection ... study, published Jan. 19 in the journal Critical ... in the normal IV nutrient solution given to patients ...
... ... Treatment , ... (Vocus) January 19, 2010 -- During Glaucoma Awareness Month, Summit Medical Group wants to help ... that causes vision loss. Because there often are no symptoms in its early stages, many ...
... ... Employers in the United States have become less satisfied with their ... Institute. Hit hard by the recession, employers of all ... the value they derive from it. They are looking to their ...
Cached Medicine News:Health News:Online Tools to Transform the Way People Manage Their Health 2Health News:Online Tools to Transform the Way People Manage Their Health 3Health News:World's #1 Health Brand for Kids Joins Forces With World's #1 In-School Children's Theatre 2Health News:World's #1 Health Brand for Kids Joins Forces With World's #1 In-School Children's Theatre 3Health News:World's #1 Health Brand for Kids Joins Forces With World's #1 In-School Children's Theatre 4Health News:High Rates of Birth Defects Found in Autistic Children 2Health News:Adding Fish Oil to IV May Speed Sepsis Recovery 2Health News:January is Glaucoma Awareness Month 2Health News:Employer Satisfaction with Health Insurers is Declining, Finds PricewaterhouseCoopers Study 2Health News:Employer Satisfaction with Health Insurers is Declining, Finds PricewaterhouseCoopers Study 3Health News:Employer Satisfaction with Health Insurers is Declining, Finds PricewaterhouseCoopers Study 4Health News:Employer Satisfaction with Health Insurers is Declining, Finds PricewaterhouseCoopers Study 5Health News:Employer Satisfaction with Health Insurers is Declining, Finds PricewaterhouseCoopers Study 6Health News:Employer Satisfaction with Health Insurers is Declining, Finds PricewaterhouseCoopers Study 7
(Date:3/3/2015)... , March 3, 2015  Blueprint Medicines ... discover, develop and commercialize novel drug candidates for ... cause of a rare genetic disease. Blueprint Medicines ... identify and optimize drug candidates and will conduct ... an Investigational New Drug (IND) application with the ...
(Date:3/3/2015)... Surgical Company (NASDAQ: STAA ) a leading developer, ... the eye, has named Caren Mason President and ... to STAAR,s Board of Directors in June 2014, and was ... Committee in September 2014, replaces Barry G. Caldwell ... Ms. Mason joins STAAR after most recently serving as CEO ...
(Date:3/3/2015)... 2015 Although lung cancer is the third ... only 18 drugs in the market for its treatment. ... nearing their patent expiry in 2015 and 2017 respectively. ... potential that drug manufacturers are vying to tap into. ... lung cancer (SCLC) and non-small cell lung cancer (NSCLC) ...
Breaking Medicine Technology:Blueprint Medicines Announces Strategic Collaboration with Alexion to Advance Kinase Drug Candidates in Rare Genetic Disease 2Caren Mason Appointed President & CEO of STAAR Surgical Company 2Caren Mason Appointed President & CEO of STAAR Surgical Company 3Caren Mason Appointed President & CEO of STAAR Surgical Company 4Caren Mason Appointed President & CEO of STAAR Surgical Company 5Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 2Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 3
... Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR ) today announced ... JMP Securities Tenth Annual Research Conference on ... the Ritz-Carlton in San Francisco. Bank of America Merrill ... at 9:50 a.m. Pacific Time at Encore at Wynn Las ...
... Halozyme Therapeutics, Inc. (Nasdaq: HALO ), ... extracellular matrix , today announced it plans to ... 6, 2011 before the open of the financial markets. ... with the investment community at 8:00 a.m. PDT (11:00 ...
Cached Medicine Technology:Optimer Pharmaceuticals to Present at May 2011 Investor Conferences 2Halozyme Therapeutics to Host First Quarter 2011 Financial Results Conference Call on May 6 2
Straight shafts and serrated handle with polished finish. Teeth: Fine 1 x 2 teeth. Most popular size or model....
Straight shafts with fine Pierse type tips. Flat smooth handle with dull finish....
Serrated handle with polished finish. Non-magnetic. Straight tips: Delicate 11 mm. Most popular size or model....
Serrated handle with polished finish. Straight tips: Delicate 11 mm. Most popular size or model....
Medicine Products: